Literature DB >> 19698913

Nonmelanoma skin cancer.

David A Lee1, Stanley J Miller.   

Abstract

This article provides readers with a comprehensive review of the evaluation and management of nonmelanoma skin cancers. Treatment recommendations are heavily based on the most recent guidelines from the National Comprehensive Cancer Network. Merkel cell carcinoma and dermatofibrosarcoma protuberans are also discussed. After reviewing this article, readers should be equipped with a better understanding of these entities and the current recommendations for their management.

Entities:  

Mesh：

Year:  2009        PMID： 19698913     DOI： 10.1016/j.fsc.2009.04.004

Source DB:  PubMed          Journal:  Facial Plast Surg Clin North Am        ISSN： 1064-7406            Impact factor:   1.918


  10 in total

1.  Squamous Cell Carcinoma - Similarities and Differences among Anatomical Sites.

Authors:  Wusheng Yan; Ignacio I Wistuba; Michael R Emmert-Buck; Heidi S Erickson
Journal:  Am J Cancer Res       Date:  2011-01-01       Impact factor: 6.166

2.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Authors:  Sadegh Amini; Martha H Viera; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

3.  PKK deletion in basal keratinocytes promotes tumorigenesis after chemical carcinogenesis.

Authors:  Luojing Chen; Matthew S Hayden; Elaine S Gilmore; Carolina Alexander-Savino; David Oleksyn; Kathleen Gillespie; Jiyong Zhao; Brian Poligone
Journal:  Carcinogenesis       Date:  2018-03-08       Impact factor: 4.944

4.  The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature.

Authors:  Luowei Li; Suneet Shukla; Andrew Lee; Susan H Garfield; David J Maloney; Suresh V Ambudkar; Stuart H Yuspa
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

Review 5.  Radiotherapy in the Adjuvant and Advanced Setting of CSCC.

Authors:  Paolo Muto; Francesco Pastore
Journal:  Dermatol Pract Concept       Date:  2021-10-01

6.  ATR-FTIR spectroscopy for the assessment of biochemical changes in skin due to cutaneous squamous cell carcinoma.

Authors:  Cássio A Lima; Viviane P Goulart; Luciana Côrrea; Thiago M Pereira; Denise M Zezell
Journal:  Int J Mol Sci       Date:  2015-03-24       Impact factor: 5.923

Review 7.  Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art.

Authors:  Shubhra Rai; Vikas Pandey; Gopal Rai
Journal:  Nano Rev Exp       Date:  2017-06-07

Review 8.  Targeted Therapy Against the Cell of Origin in Cutaneous Squamous Cell Carcinoma.

Authors:  Stephen J Goldie; Ginevra Chincarini; Charbel Darido
Journal:  Int J Mol Sci       Date:  2019-05-05       Impact factor: 5.923

9.  Nonmelanoma Skin Cancer at Critical Facial Sites: Results and Strategies of the Surgical Treatment of 102 Patients.

Authors:  Carlos Alberto Ferreira de Freitas; Andreza Negreli Santos; Guilherme Canho Bittner; Baltazar Dias Sanabria; Maria Margarida Morena Domingos Levenhagen; Günther Hans-Filho
Journal:  J Skin Cancer       Date:  2019-06-26

10.  Circulating Immunosuppressive Regulatory T Cells Predict Risk of Incident Cutaneous Squamous Cell Carcinoma.

Authors:  Dana E Rollison; Jane L Messina; Basil S Cherpelis; Neil A Fenske; Michael J Schell; Dennis O Adeegbe; Yayi Zhao; Rossybelle P Amorrortu; Afua A Akuffo; Rebecca S Hesterberg; Pearlie K Epling-Burnette
Journal:  Front Med (Lausanne)       Date:  2021-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.